Based on these findings we have proposed a mechanism on how circulating miRNAs may potentially control the expression corresponding targets and how their regulatory networks may govern different stages of the insulin pathway in the pathogenesis of T2D (Fig. 12) [31], [34], [46], [50], [67]–[69]. The gene discussed is INS; the disease is type 2 diabetes mellitus.